TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation

Cited by (362)

Items 101–200 of 362

1. Dectin-1-induced RIPK1 and RIPK3 activation protects host against Candida albicans infection
   Mengtao Cao, Zhengxi Wu, Qi Lou, Wenli Lü, Jie Zhang, Qi Li, Yifan Zhang, Yikun Yao, Qun Zhao, Ming Li et al. · 2019 · Cell Death and Differentiation
2. The Many Faces of MLKL, the Executor of Necroptosis
   Veronica Martinez-Osorio, Yasmin Abdelwahab, Uris Ros · 2023 · International Journal of Molecular Sciences
3. Salmonella Effectors SseK1 and SseK3 Target Death Domain Proteins in the TNF and TRAIL Signaling Pathways*
   Joshua P. M. Newson, Nichollas E. Scott, Ivy Yeuk Wah Chung, Tania Wong Fok Lung, Cristina Giogha, Jiyao Gan, Nancy Wang, Richard A. Strugnell, Nathaniel F. Brown, Mirosław Cygler et al. · 2019 · Molecular & Cellular Proteomics
4. Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma
   Vijay G. Ramakrishnan, Utkarsh Painuly, Teresa K. Kimlinger, Janine Haug, S. Vincent Rajkumar, Shaji Kunnathu Kumar · 2014 · Leukemia
5. Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
   Jing Zhu, Meng Xin, Congcong Xu, Yuan He, Wannian Zhang, Zhibin Wang, Chunlin Zhuang · 2021 · Acta Pharmaceutica Sinica B
6. Targeting cell death signaling in colorectal cancer: Current strategies and future perspectives
   Bruno Christian Koehler · 2014 · World Journal of Gastroenterology
7. The role of RIPK1 mediated cell death in acute on chronic liver failure
   Takayuki Kondo, Stewart Macdonald, Cornelius Engelmann, Abeba Habtesion, Jane Macnaughtan, Gautam Mehta, Rajeshwar P. Mookerjee, Nathan A. Davies, Marco Pavesi, Richard Moreau et al. · 2021 · Cell Death and Disease
8. Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
   Xiangbo Yang, Huimin Lu, Hang Xie, Binbin Zhang, Tianqing Nie, Chen Fan, Tao Yang, Yechun Xu, Haixia Su, Wei Tang et al. · 2021 · Angewandte Chemie International Edition
9. Genipin protects d-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the necroptosis-mediated inflammasome signaling
   Min-Jong Seo, Jeong‐Min Hong, Seok‐Joo Kim, Sun‐Mee Lee · 2017 · European Journal of Pharmacology
10. MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells
    Lin Jing, Fei Song, Zhenyu Liu, Jianghua Li, Bo Wu, Zhiguang Fu, Jian‐Li Jiang, Zhi‐Nan Chen · 2017 · Cancer Letters
11. Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance
    Valeriya Gyurkovska, Nina Ivanovska · 2016 · Inflammation Research
12. Necroptosis: An emerging type of cell death in liver diseases
    Waqar Khalid Saeed · 2014 · World Journal of Gastroenterology
13. Necroptotic Cell Death in Liver Transplantation and Underlying Diseases: Mechanisms and Clinical Perspective
    Shaojun Shi, Monique M. A. Verstegen, Laura Mezzanotte, Jeroen de Jonge, Clemens W.G.M. Löwik, Luc J. W. van der Laan · 2019 · Liver Transplantation
14. Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis
    Alexander Wree, Theresa Maria Holtmann, María Eugenia Inzaugarat, Ariel E. Feldstein · 2019 · Seminars in Liver Disease
15. Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity
    Rebecca Voltan, Paola Secchiero, Fabio Casciano, Daniela Milani, Giorgio Zauli, Veronica Tisato · 2016 · The International Journal of Biochemistry & Cell Biology
16. TRAIL Modulates the Immune System and Protects against the Development of Diabetes
    Fleur Bossi, Stella Bernardi, Giorgio Zauli, Paola Secchiero, Bruno Fabris · 2015 · Journal of Immunology Research
17. Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
    Anna-Laura Kretz, Silvia von Karstedt, Andreas Hillenbrand, Doris Henne‐Bruns, Uwe Knippschild, Anna Trauzold, Johannes Lemke · 2018 · Cancers
18. The role of necroptosis in the treatment of diseases
    Young Sik Cho · 2018 · BMB Reports
19. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases
    Yi Li, Jianping Chen, Andrew A. Bolinger, Haiying Chen, Zhiqing Liu, Yingzi Cong, Allan R. Brasier, Irina V. Pinchuk, Bing Tian, Jia Zhou · 2021 · Inflammatory Bowel Diseases
20. Paving TRAIL’s Path with Ubiquitin
    Élodie Lafont, Torsten Hartwig, Henning Walczak · 2017 · Trends in Biochemical Sciences
21. The Receptor Interacting Protein Kinases in the Liver
    Lily Dara · 2018 · Seminars in Liver Disease
22. Cell Death Induction and Protection by Activation of Ubiquitously Expressed Anion/Cation Channels. Part 1: Roles of VSOR/VRAC in Cell Volume Regulation, Release of Double-Edged Signals and Apoptotic/Necrotic Cell Death
    Yasunobu Okada, Ravshan Z. Sabirov, Kaori Sato-Numata, Tomohiro Numata · 2021 · Frontiers in Cell and Developmental Biology
23. FAF1 mediates regulated necrosis through PARP1 activation upon oxidative stress leading to dopaminergic neurodegeneration
    Changsun Yu, Bok‐Seok Kim, Eunhee Kim · 2016 · Cell Death and Differentiation
24. Drug antagonism and single-agent dominance result from differences in death kinetics
    Ryan Richards, Hannah R. Schwartz, Megan E. Honeywell, Mariah S. Stewart, Peter Cruz‐Gordillo, Anna J. Joyce, Benjamin D. Landry, Michael J. Lee · 2020 · Nature Chemical Biology
25. Receptor interacting protein 3-induced RGC-5 cell necroptosis following oxygen glucose deprivation
    Wei Ding, Lei Shang, Ju-Fang Huang, Na Li, Dan Chen, Lixiang Xue, Kun Xiong · 2015 · BMC Neuroscience
26. Overcoming TRAIL Resistance for Glioblastoma Treatment
    Longfei Deng, Xuan Zhai, Ping Liang, Hongjuan Cui · 2021 · Biomolecules
27. P2X7 Receptor and Purinergic Signaling: Orchestrating Mitochondrial Dysfunction in Neurodegenerative Diseases
    A. S. Zelentsova, Alexey V. Deykin, Vladislav O. Soldatov, Anastasia A. Ulezko, Alina Y. Borisova, Veronika S. Belyaeva, M. Yu. Skorkina, Plamena R. Angelova · 2022 · eNeuro
28. Necrostatin-1 enhances the resolution of inflammation by specifically inducing neutrophil apoptosis
    Hongyu Jie, Yi He, Xuechan Huang, Qingyou Zhou, Yanping Han, Xing Li, Yongkun Bai, Erwei Sun · 2016 · Oncotarget
29. The role of necroptosis in pulmonary diseases
    Kenji Mizumura, Shuichiro Maruoka, Yasuhiro Gon, Augustine M.K. Choi, Shu Hashimoto · 2016 · Respiratory Investigation
30. Carbon Nanodots for On Demand Chemophotothermal Therapy Combination to Elicit Necroptosis: Overcoming Apoptosis Resistance in Breast Cancer Cell Lines
    Aldo Nicosia, Gennara Cavallaro, Salvatore Costa, Mara Andrea Utzeri, Angela Cuttitta, Gaetano Giammona, Nicolò Mauro · 2020 · Cancers
31. Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials
    Run Song, Shiyi Yin, Jiannan Wu, Junqiang Yan · 2024 · Neural Regeneration Research
32. PARP1-mediated necrosis is dependent on parallel JNK and Ca2+/calpain pathways
    Diana L. Douglas, Christopher P. Baines · 2014 · Journal of Cell Science
33. Hyaluronic acid dressing of hydrophobic carbon nanodots: A self-assembling strategy of hybrid nanocomposites with theranostic potential
    Nicolò Mauro, Mara Andrea Utzeri, Salvatore Emanuele Drago, Aldo Nicosia, Salvatore Costa, Gennara Cavallaro, Gaetano Giammona · 2021 · Carbohydrate Polymers
34. Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches
    Jiacheng Zhang, Xinli Hu, Yibo Geng, Linyi Xiang, Yuzhe Wu, Yao Li, Liangliang Yang, Kailiang Zhou · 2024 · Journal of Advanced Research
35. Ceramide Induces the Death of Retina Photoreceptors Through Activation of Parthanatos
    Facundo H. Prado Spalm, Marcela S. Vera, Marcos Dibo, M. Victoria Simón, Luis E. Politi, Nora P. Rotstein · 2018 · Molecular Neurobiology
36. Eukaryotic initiation factor 5B (eIF5B) provides a critical cell survival switch to glioblastoma cells via regulation of apoptosis
    Joseph A. Ross, Keiran Vanden Dungen, Kamiko R. Bressler, Mikayla Fredriksen, Divya Khandige Sharma, Nirujah Balasingam, Nehal Thakor · 2019 · Cell Death and Disease
37. Chronic Ethanol Consumption Induces Osteopenia via Activation of Osteoblast Necroptosis
    Man Guo, Yongli Huang, Qi Wu, Li Chai, Zongzhe Jiang, Yan Zeng, Shengrong Wan, Xiaozhen Tan, Yang Long, Junling Gu et al. · 2021 · Oxidative Medicine and Cellular Longevity
38. Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
    Manjari Kundu, Yoshimi Endo Greer, Jennifer L. Dine, Stanley Lipkowitz · 2022 · Cells
39. The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver
    Muhammad Imran Arshad, Claire Piquet‐Pellorce, Aveline A. Filliol, Annie L’Helgoualc’h, Catherine Lucas‐Clerc, Sandrine Jouan-Lanhouet, Marie‐Thérèse Dimanche‐Boitrel, Michel Samson · 2015 · Journal of Molecular Medicine
40. Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence
    Chrysi C. Koliaki, Nicholas L. Katsilambros · 2022 · International Journal of Molecular Sciences
41. The role of necroptosis, an alternative form of cell death, in cancer therapy
    Xinfang Yu, Qipan Deng, Ann M. Bode, Zigang Dong, Ya Cao · 2013 · Expert Review of Anticancer Therapy
42. Anti-proliferative and cytotoxic activities of the flavonoid isoliquiritigenin in the human neuroblastoma cell line SH-SY5Y
    Escobar, Stephane J.de M., Fong, Genevieve M., Winnischofer, Sheila M.B., Simone, Martin, Munoz, Lenka, Dennis, Joanne M., Rocha, Maria Eliane M., Witting, Paul K. · 2019 · Chemico-Biological Interactions
43. Sibiriline, a new small chemical inhibitor of receptor‐interacting protein kinase 1, prevents immune‐dependent hepatitis
    Fabienne Le Cann, Claire Delehouzé, Sabrina Leverrier, Aveline A. Filliol, Arnaud Comte, Olivier Delalande, Nathalie Desban, Blandine Baratte, Isabelle Gallais, Claire Piquet‐Pellorce et al. · 2017 · FEBS Journal
44. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor
    Zuzana Nahácka, Jan Švadlenka, Martin Peterka, Marie Ksandrová, Simona Benesova, Jiřı́ Neužil, Ladislav Anděra · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
45. Bortezomib-Loaded Mesoporous Silica Nanoparticles Selectively Alter Metabolism and Induce Death in Multiple Myeloma Cells
    Alessandra Nigro, Luca Frattaruolo, Mariarosa Fava, Ilaria De Napoli, Marianna Greco, Alessandra Comandé, Marzia De Santo, MICHELE A. PELLEGRINO, Elena Delfina Ricci, Francesca Giordano et al. · 2020 · Cancers
46. The regulation of necroptosis by ubiquitylation
    Yiliang Chen, Wenqing Ren, Qingsong Wang, Yuan He, Dan Ma, Zhenyu Cai · 2022 · APOPTOSIS
47. Nano-plastics and gastric health: Decoding the cytotoxic mechanisms of polystyrene nano-plastics size
    Mingming Han, Tian Zhu, Ji Liang, Hong Wang, Chenxi Zhu, Anisah Lee Binti Abdullah, James Rubinstein, Richard Worthington, Andrew George, Yiming Li et al. · 2023 · Environment International
48. A narrative review of the role of necroptosis in liver disease: a double-edged sword
    Xuehui Li, Guanjun Dong, Huabao Xiong, Hongyan Diao · 2021 · Annals of Translational Medicine
49. High Glucose-Induced Kidney Injury via Activation of Necroptosis in Diabetic Kidney Disease
    Man Guo, Qing Chen, Yongli Huang, Qi Wu, Yan Zeng, Xiaozhen Tan, Fang‐Yuan Teng, Xiumei Ma, Yueli Pu, Wei Gang Huang et al. · 2023 · Oxidative Medicine and Cellular Longevity
50. Targeting intestinal epithelial cell–programmed necrosis alleviates tissue injury after intestinal ischemia/reperfusion in rats
    Xiang Li, Yihong Ling, Zhongming Cao, Jiantong Shen, Shaoqian Chen, Weifeng Liu, Bao-Long Yuan, Shihong Wen · 2018 · Journal of Surgical Research
51. Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor
    Tom Delanghe, Jon Huyghe, Seungheon Lee, Dario Priem, Samya Van Coillie, Barbara Gilbert, Sze Men Choi, Peter Vandenabeele, Alexei Degterev, Gregory D. Cuny et al. · 2021 · Cell Death and Disease
52. Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury
    Lijuan Xu, Ye Tu, Jiao Li, Wannian Zhang, Zhibin Wang, Chunlin Zhuang, Lei Xue · 2021 · Chinese Chemical Letters
53. Specific and shared biological functions of PARP2 – is PARP2 really a lil’ brother of PARP1?
    Magdolna Szántó, José Yélamos, Péter Bai · 2024 · Expert Reviews in Molecular Medicine
54. Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism
    J Bullenkamp, Nina Raulf, Bushra Ayaz, Henning Walczak, Dagmar Kulms, Edward William Odell, Selvam Thavaraj, M Tavassoli · 2014 · Cell Death and Disease
55. Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells
    Justyna Sosna, Stephan Philipp, Johaiber Fuchslocher Chico, Carina Saggau, Jürgen H. Fritsch, Alexandra Föll, Johannes Plenge, Christoph Arenz, Thomas Pinkert, Holger Kalthoff et al. · 2016 · Molecular and Cellular Biology
56. Proteasome inhibition blocks necroptosis by attenuating death complex aggregation
    Mohammad Ali, Edward S. Mocarski · 2018 · Cell Death and Disease
57. Necroptosis in Cholangiocarcinoma
    Samantha Sarcognato, Iris E. M. de Jong, Luca Fabris, Massimiliano Cadamuro, Maria Guido · 2020 · Cells
58. Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells
    Valeria Pavet, Yelyzaveta Shlyakhtina, Tao He, Danilo G. Ceschin, Pekka J. Kohonen, Merja Perälä, Olli Kallioniemi, Hinrich Gronemeyer · 2014 · Cell Death and Disease
59. Non-Canonical Programmed Cell Death in Colon Cancer
    Bingchen Pan, Bowen Zheng, Chengzhong Xing, Jingwei Liu · 2022 · Cancers
60. Differential sensitivity of metabolically competent and non-competent HepaRG cells to apoptosis induced by diclofenac combined or not with TNF-α
    Houssein Al‐Attrache, Ahmad Sharanek, Audrey Burban, Matthew Burbank, Thomas Gicquel, Ziad Abdel‐Razzak, Christiane Guguen‐Guillouzo, Isabelle Morel, André Guillouzo · 2016 · Toxicology Letters
61. TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
    Stella Bernardi, Rebecca Voltan, Erika Rimondi, Elisabetta Melloni, Daniela Milani, Carlo Cervellati, Donato Gemmati, Claudio Celeghini, Paola Secchiero, Giorgio Zauli et al. · 2019 · Clinical Science
62. Role of programmed necrosis and cell death in intestinal inflammation
    Maryse Dagenais, Todd Douglas, Maya Saleh · 2014 · Current Opinion in Gastroenterology
63. Sensitivity of Malignant Peripheral Nerve Sheath Tumor Cells to TRAIL Is Augmented by Loss of NF1 through Modulation of MYC/MAD and Is Potentiated by Curcumin through Induction of ROS
    David Reuß, Jana Mucha, Christian Hagenlocher, Volker Ehemann, Lan Kluwe, Victor Mautner, Andreas von Deimling · 2013 · PLoS ONE
64. Induced Necroptosis and Its Role in Cancer Immunotherapy
    Ziyao Zhang, Fangming Zhang, Wenjing Xie, Yubo Niu, Haonan Wang, Guofeng Li, Lingyun Zhao, Xing Wang, Wensheng Xie · 2024 · International Journal of Molecular Sciences
65. Necroptosis inhibitors as therapeutic targets in inflammation mediated disorders - a review of the current literature and patents
    Spandana Rajendra Kopalli, Tae‐Bong Kang, Sushruta Koppula · 2016 · Expert Opinion on Therapeutic Patents
66. Disrupting mitochondrial Ca2+ homeostasis causes tumor-selective TRAIL sensitization through mitochondrial network abnormalities
    Yohei Ohshima, Natsuhiko Takata, Miki Suzuki‐Karasaki, Yukihiro Yoshida, Yasuaki Tokuhashi, Yoshihiro Suzuki‐Karasaki · 2017 · International Journal of Oncology
67. Suppressing PARylation by 2′,5′‐oligoadenylate synthetase 1 inhibits DNA damage‐induced cell death
    Anna A. Kondratova, HyeonJoo Cheon, Beihua Dong, Elise G. Holvey-Bates, Metis Hasipek, Irina Taran, Christina Gaughan, Babal Kant Jha, Robert H. Silverman, George Robert Stark · 2020 · The EMBO Journal
68. Reprogramming of Cell Death Pathways by Bacterial Effectors as a Widespread Virulence Strategy
    Joseph J. Wanford, Abderrahman Hachani, Charlotte Odendall · 2022 · Infection and Immunity
69. The effect and underlying mechanism of Timosaponin B-II on RGC-5 necroptosis induced by hydrogen peroxide
    San-Hong Jiang, Lei Shang, Lixiang Xue, Wei Ding, Shuang Chen, Ruo-Fei Ma, Ju-Fang Huang, Kun Xiong · 2014 · BMC Complementary and Alternative Medicine
70. Necrosis as Programmed Cell Death
    Ma. Luisa Escobar, Olga M. Echeverría, Gerardo H. Vázquez‐Nin · 2015 · InTech eBooks
71. Programmed cell death, from liver Ischemia–Reperfusion injury perspective: An overview
    Shao-Bin Luo, Rongkun Luo, Gang Deng, Feizhou Huang, Zhao Lei · 2024 · Heliyon
72. Association of Plasma Level of TNF-Related Apoptosis-Inducing Ligand with Severity and Outcome of Sepsis
    Hongseok Yoo, Jin Young Lee, Junseon Park, Jeong Hoon Yang, Gee Young Suh, Kyeongman Jeon · 2020 · Journal of Clinical Medicine
73. Acute lung injury: a view from the perspective of necroptosis
    Jinyan Dong, Weihong Liu, Wenli Liu, Yuqi Wen, Qingkuo Liu, Hong-Tao Wang, Guo-han Xiang, Yang Liu, Hao Hao · 2024 · Inflammation Research
74. TRAIL-Based Therapy in Pediatric Bone Tumors: How to Overcome Resistance
    Romain Guiho, Kévin Biteau, Dominique Heymann, Françoise Rédiní · 2015 · Future Oncology
75. Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy
    Gertrud Knoll, Sebastian Bittner, Maria Kurz, Jonathan Jantsch, Martin Ehrenschwender · 2016 · Oncotarget
76. Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity
    Zhanhui Li, Yongjin Hao, Chengkui Yang, Qing Yang, Shuwei Wu, Haikuo Ma, Sheng Tian, Haohao Lu, Jingrui Wang, Tao Yang et al. · 2021 · European Journal of Medicinal Chemistry
77. Gambogic acid sensitizes breast cancer cells to TRAIL-induced apoptosis by promoting the crosstalk of extrinsic and intrinsic apoptotic signalings
    Shengpeng Wang, Yingqi Xu, Chenyang Li, Hongxun Tao, Anqi Wang, Chenyu Sun, Zhangfeng Zhong, Xu Wu, Peng Li, Yitao Wang · 2018 · Food and Chemical Toxicology
78. TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE-/- Mice
    Siân Peta Cartland, Jonathan Erlich, Mary Meltem Kavurma · 2014 · PLoS ONE
79. Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell Death
    Ana C. Paim, Andrew D. Badley, Nathan W. Cummins · 2019 · AIDS Research and Human Retroviruses
80. Protective Effects of Necrostatin-1 in Acute Pancreatitis: Partial Involvement of Receptor Interacting Protein Kinase 1
    Yulin Ouyang, Li Wen, Jane A. Armstrong, Michael Chvanov, Diane Latawiec, Wenhao Cai, Mohammad Awais, Rajarshi Mukherjee, Wei Huang, Peter J. Gough et al. · 2021 · Cells
81. The molecular mechanism of acute liver injury and inflammatory response induced by Concanavalin A
    Xiaoxiao Liu, Ting Yu, Yuzhu Hu, Longzhen Zhang, Junnian Zheng, Xiawei Wei · 2021 · Molecular Biomedicine
82. Direct estradiol and diethylstilbestrol actions on early- versus late-stage prostate cancer cells
    Luke Y. Koong, Cheryl S. Watson · 2014 · The Prostate
83. PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway
    Yuta Kishi, Hisako Fujihara, Koji Kawaguchi, Hiroyuki Yamada, Ryoko Ushikoshi‐Nakayama, Nanami Yamamoto, Yuko Fujihara, Yoshiki Hamada, Kazuhito Satomura, Mitsuko Masutani · 2015 · International Journal of Molecular Sciences
84. TRPC6 May Protect Renal Ischemia-Reperfusion Injury Through Inhibiting Necroptosis of Renal Tubular Epithelial Cells
    Bingbing Shen, Yue He, Shan Zhou, Hongwen Zhao, Mei Mei, Xiongfei Wu · 2016 · Medical Science Monitor
85. Kinase-independent role of nuclear RIPK1 in regulating parthanatos through physical interaction with PARP1 upon oxidative stress
    Ki-Hong Jang, Taeik Jang, Eunji Son, Soonjin Choi, Eunhee Kim · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
86. Bulnesia sarmientoi Supercritical Fluid Extract Exhibits Necroptotic Effects and Anti-Metastatic Activity on Lung Cancer Cells
    Heng-Long Wang, Jung-Che Chang, Li-Wen Fang, Hsia‐Fen Hsu, Li-Chiun Lee, Jyh‐Ferng Yang, Ming‐Tsai Liang, Pei-Chi Hsiao, Chao-Ping Wang, Shih‐Wei Wang et al. · 2018 · Molecules
87. DR4-Ser424O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death
    Hyeon-Jeong Lee, Yumin Oh, Young-Jun Jeon, Song-Yi Lee, Hyun‐Joo Kim, Ho-June Lee, Yong‐Keun Jung · 2019 · Cancer Research
88. Programmed cell death in triple-negative breast cancer
    Yaqi Liu, Jin‐Wei He, Jialu Chen, Tianhui Chen, Wei Li, Zhihui Yang, Fancai Zeng · 2025 · Cellular & Molecular Biology Letters
89. Diverse pathways to neuronal necroptosis in Alzheimer's disease
    Anusha Jayaraman, Richard Reynolds · 2022 · European Journal of Neuroscience
90. Necrostatin-1 Protects Against d-Galactosamine and Lipopolysaccharide-Induced Hepatic Injury by Preventing TLR4 and RAGE Signaling
    Seok‐Joo Kim, Sun‐Mee Lee · 2017 · Inflammation
91. Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab
    Maria Sole Chimenti, Paola Tucci, Eleonora Candi, Roberto Perricone, Gerry Melino, Anne E. Willis · 2013 · Cell Cycle
92. Salmonella‑induced miR‑155 enhances necroptotic death in macrophage cells via targeting RIP1/3
    Young‐Tae Ro, Guk‐Heui Jo, Sun‐Ah Jung, Eunjoo Hwang Lee, Jongdae Shin, Joon Lee · 2018 · Molecular Medicine Reports
93. The Role of Anesthetic Drugs in Liver Apoptosis
    Ali Dabbagh, Samira Rajaei · 2013 · Hepatitis Monthly
94. A murder mystery in the liver: who done it and how?
    Lily Dara, Zhang‐Xu Liu, Neil Kaplowitz · 2016 · Journal of Clinical Investigation
95. Enzymatic Insertion of Lipids Increases Membrane Tension for Inhibiting Drug Resistant Cancer Cells
    Jiaqing Wang, Weiyi Tan, Guanying Li, Difei Wu, Hongjian He, Jiashu Xu, Meihui Yi, Ye Zhang, S. Ali Aghvami, Seth Fraden et al. · 2020 · Chemistry - A European Journal
96. Advances in the regulatory mechanisms of mTOR in necroptosis
    Yawen Xie, Guoyu Zhao, Xianli Lei, Na Cui, Hao Wang · 2023 · Frontiers in Immunology
97. The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo
    Konstantinos Kelepouras, Julia Saggau, Ana Beatriz Varanda, Matea Zrilić, Christine Kiefer, Hassan Rakhsh-Khorshid, Ina Lisewski, Iratxe Uranga-Murillo, Maykel A. Arias, Julián Pardo et al. · 2024 · Cell Death and Differentiation
98. Cell Death in Crustacean Immune Defense
    Zeyan Chen, Muhammad Tayyab, Defu Yao, Jude Juventus Aweya, Zhi‐Hong Zheng, Xianliang Zhao, Zhongyang Lin, Yueling Zhang · 2024 · Reviews in Aquaculture
99. RIPK3 in necroptosis and cancer
    Michael John Morgan, You‐Sun Kim · 2025 · Molecules and Cells
100. LiCl Treatment Induces Programmed Cell Death of Schwannoma Cells through AKT- and MTOR-Mediated Necroptosis
     Ying Wang, Qi Zhang, Bo Wang, Peng Li, Pinan Liu · 2017 · Neurochemical Research